Archive - March 2021
Have Recalls of Male Enhancement Products Begun?
Amgen plans acquisition of Rodeo Therapeutics
Novartis bolsters radioligand therapy pipeline with new licence agreement
BioNTech forecasts €9.8bn in sales of Pfizer-partnered COVID-19 vaccine in 2021
Just 2 weeks left until INTCR 2021 closes for entry
BMS’ Opdivo plus LAG-3 antibody relatlimab show promise in melanoma
Roche scores EU approval for at-home SMA treatment Evrysdi
NICE recommends Sobi’s Kineret for first-line use in Still’s disease